Showing results (11-20 of 232) with videos related to

Sort By:
Pageof 24
Molecular Carcinogenesis|February 3, 2015
The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinomaHan Zhuo, Junwei Tang, Zhe Lin, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 26, 2015
Aggravated Liver Injury but Attenuated Inflammation in PTPRO-Deficient Mice Following LPS/D-GaIN Induced Fulminant HepatitisXiaochen Wang, Shushan Yan, Donghua Xu, et al.
Hepatology (Baltimore, Md.)|July 24, 2012
Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3Jiajie Hou, Juan Xu, Runqiu Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
miR-22 promotes HBV-related hepatocellular carcinoma development in malesRunqiu Jiang, Lei Deng, Liang Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 28, 2015
Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasisLei Deng, Hui Yang, Junwei Tang, et al.
Journal of Hepatology|October 17, 2013
PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κBJiajie Hou, Yongxiang Xia, Runqiu Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2013
IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activationZhongming Tan, Xiaofeng Qian, Runqiu Jiang, et al.
Pageof 24